financetom
Business
financetom
/
Business
/
Fresenius Medical Care Shares Decline Following Q1 Results
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fresenius Medical Care Shares Decline Following Q1 Results
May 7, 2024 11:11 AM

01:48 PM EDT, 05/07/2024 (MT Newswires) -- Fresenius Medical Care ( FMS ) shares were down more than 6% in recent Tuesday trading after the company reported its Q1 earnings.

The company reported Q1 earnings of 0.24 euro ($0.26) per share, down from 0.29 euro a year earlier.

One analyst polled by Capital IQ expected 0.04 euro.

Revenue for the quarter ended March 31 was 4.73 billion euros, up from 4.7 billion euros a year earlier.

Analysts surveyed by Capital IQ expected 4.73 billion euros.

Price: 20.06, Change: -1.37, Percent Change: -6.37

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Immuneering Shares Surge Premarket as 'Positive' Data Seen in Phase 2a Pancreatic Cancer Trial
Update: Immuneering Shares Surge Premarket as 'Positive' Data Seen in Phase 2a Pancreatic Cancer Trial
Sep 13, 2024
04:41 AM EDT, 09/13/2024 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Immuneering ( IMRX ) shares rose more than 30% in premarket activity Friday after saying that a complete or partial response was observed in the first two patients with first-line pancreatic cancer getting IMM-1-104 in combination with modified gemcitabine/nab-paclitaxel in a...
Unicredit and German government talk after Commerzbank stake purchase, source says
Unicredit and German government talk after Commerzbank stake purchase, source says
Sep 13, 2024
BERLIN (Reuters) -German government officials and UniCredit bankers have held talks after the Italian lender bought a 9% stake in Commerzbank, a German government source said on Friday. The talks, reported for the first time, is a significant development in the possible acquisition of one of Germany's largest banks by a foreign institution. UniCredit declined to comment. Earlier this week,...
Halozyme Therapeutics Insider Sold Shares Worth $1,773,790, According to a Recent SEC Filing
Halozyme Therapeutics Insider Sold Shares Worth $1,773,790, According to a Recent SEC Filing
Sep 13, 2024
03:33 AM EDT, 09/13/2024 (MT Newswires) -- Helen Torley, Director, President and Chief Executive Officer, on September 10, 2024, sold 30,000 shares in Halozyme Therapeutics ( HALO ) for $1,773,790. Following the Form 4 filing with the SEC, Torley has control over a total of 676,744 shares of the company, with 676,744 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1159036/000141588924023307/xslF345X05/form4-09122024_090954.xml Price: 60.00,...
Beijing suspends PwC's China unit for six months over Evergrande audit
Beijing suspends PwC's China unit for six months over Evergrande audit
Sep 13, 2024
HONG KONG/BEIJING (Reuters) -China's Ministry of Finance (MOF) on Friday imposed a six-month business suspension on PwC's auditing unit in mainland China over its audit of troubled property developer China Evergrande Group ( EGRNF ), the regulator said. The ministry also imposed a fine of 116 million yuan ($16 million) on PwC Zhong Tian LLP, the registered accounting entity and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved